{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:22:23Z","timestamp":1762352543716,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T00:00:00Z","timestamp":1480032000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["CVON 2011\/ B019"],"award-info":[{"award-number":["CVON 2011\/ B019"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0397-x","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T08:07:17Z","timestamp":1480061237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study"],"prefix":"10.1186","volume":"16","author":[{"given":"Sophie J.","family":"Bernelot Moens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Stoekenbroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fleur M.","family":"van der Valk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone L.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J. W.","family":"Koelemay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein J.","family":"Verberne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Nieuwdorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik S. G.","family":"Stroes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"key":"397_CR1","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/eurheartj\/ehv630","volume":"37","author":"RM Stoekenbroek","year":"2016","unstructured":"Stoekenbroek RM, Boekholdt SM, Luben R, Hovingh GK, Zwinderman AH, Wareham NJ, et al. Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study. Eur Heart J. 2016;37:880\u20139.","journal-title":"Eur Heart J"},{"key":"397_CR2","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","volume":"297","author":"PG Steg","year":"2007","unstructured":"Steg PG, Bhatt DL, Wilson PWF, D\u2019Agostino R, Ohman EM, R\u00f6ther J, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197\u2013206.","journal-title":"JAMA"},{"key":"397_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejvs.2006.10.040","volume":"34","author":"A Abdellaoui","year":"2007","unstructured":"Abdellaoui A, Al-Khaffaf H. C-reactive protein (CRP) as a marker in peripheral vascular disease. Eur J Vasc Endovasc Surg. 2007;34:18\u201322.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"397_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ejvs.2007.10.016","volume":"35","author":"J Haro De","year":"2008","unstructured":"De Haro J, Acin F, Lopez-Quintana A, Medina FJ, Martinez-Aguilar E, Florez A, et al. Direct association between C-reactive protein serum levels and endothelial dysfunction in patients with claudication. Eur J Vasc Endovasc Surg. 2008;35:480\u20136.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"397_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nrcardio.2014.80","volume":"11","author":"JM Tarkin","year":"2014","unstructured":"Tarkin JM, Joshi FR, Rudd JHF. PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol. 2014;11:443\u201357. Nature Publishing Group.","journal-title":"Nat Rev Cardiol"},{"key":"397_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11307-009-0223-2","volume":"11","author":"JA Wass\u00e9lius","year":"2009","unstructured":"Wass\u00e9lius JA, Larsson SA, Jacobsson H. FDG-accumulating atherosclerotic plaques identified with 18\u00a0F-FDG-PET\/CT in 141 patients. Mol Imaging Biol. 2009;11:455\u20139.","journal-title":"Mol Imaging Biol"},{"key":"397_CR7","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1161\/01.CIR.0000020548.60110.76","volume":"105","author":"JH Rudd","year":"2002","unstructured":"Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18\u00a0F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708\u201311.","journal-title":"Circulation"},{"key":"397_CR8","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","volume":"48","author":"A Tawakol","year":"2006","unstructured":"Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18\u00a0F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"397_CR9","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jcmg.2013.08.006","volume":"6","author":"AL Figueroa","year":"2013","unstructured":"Figueroa AL, Abdelbaky A, Truong QA, Corsini E, MacNabb MH, Lavender ZR, et al. Measurement of arterial activity on routine FDG PET\/CT images improves prediction of risk of future CV events. JACC Cardiovasc Imaging. 2013;6:1250\u20139. Elsevier Inc.","journal-title":"JACC Cardiovasc Imaging"},{"key":"397_CR10","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2337\/diacare.27.12.2843","volume":"27","author":"CL Leibson","year":"2004","unstructured":"Leibson CL, Ransom JE, Olson W, Zimmerman BR, O\u2019fallon WM, Palumbo PJ. Peripheral arterial disease, diabetes, and mortality. Diabetes Care. 2004;27:2843\u20139.","journal-title":"Diabetes Care"},{"key":"397_CR11","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.jacc.2011.11.069","volume":"59","author":"J Bucerius","year":"2012","unstructured":"Bucerius J, Mani V, Moncrieff C, Rudd JHF, Machac J, Fuster V, et al. Impact of noninsulin-dependent type 2 diabetes on carotid wall 18\u00a0F-fluorodeoxyglucose positron emission tomography uptake. J Am Coll Cardiol. 2012;59:2080\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"397_CR12","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.jacc.2006.11.046","volume":"49","author":"N Tahara","year":"2007","unstructured":"Tahara N, Kai H, Yamagishi S, Mizoguchi M, Nakaura H, Ishibashi M, et al. Vascular inflammation evaluated by [18\u00a0F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol. 2007;49:1533\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"397_CR13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.atherosclerosis.2015.03.040","volume":"240","author":"RM Stoekenbroek","year":"2015","unstructured":"Stoekenbroek RM, Rensing KL, Bernelot Moens SJ, Nieuwdorp M, DeVries JH, Zwinderman AH, et al. High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events. Atherosclerosis. 2015;240:318\u201323. Elsevier Ltd.","journal-title":"Atherosclerosis"},{"key":"397_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.bbrc.2007.11.006","volume":"365","author":"K Kappert","year":"2008","unstructured":"Kappert K, Meyborg H, Clemenz M, Graf K, Fleck E, Kintscher U, et al. Insulin facilitates monocyte migration: a possible link to tissue inflammation in insulin-resistance. Biochem Biophys Res Commun. 2008;365:503\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"397_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","volume":"33","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:S1\u201375.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"397_CR16","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jcmg.2016.04.007","volume":"9","author":"FM Valk Van der","year":"2016","unstructured":"Van der Valk FM, Verweij SL, Zwinderman KAH, Strang AC, Kaiser Y, Marquering HA, et al. Thresholds for Arterial Wall Inflammation Quantified by (18)F-FDG PET Imaging: Implications for Vascular Interventional Studies. JACC Cardiovasc Imaging. 2016;9:1198\u2013207.","journal-title":"JACC Cardiovasc Imaging"},{"key":"397_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1148\/radiology.183.3.1584912","volume":"183","author":"RL Wahl","year":"1992","unstructured":"Wahl RL, Henry CA, Ethier SP. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology. 1992;183:643\u20137.","journal-title":"Radiology"},{"key":"397_CR18","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1161\/CIRCULATIONAHA.109.918417","volume":"122","author":"G Brevetti","year":"2010","unstructured":"Brevetti G, Giugliano G, Brevetti L, Hiatt WR. Inflammation in peripheral artery disease. Circulation. 2010;122:1862\u201375.","journal-title":"Circulation"},{"key":"397_CR19","first-page":"253","volume":"43","author":"SG Rockson","year":"1998","unstructured":"Rockson SG, Cooke JP. Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options. Adv Intern Med. 1998;43:253\u201377.","journal-title":"Adv Intern Med"},{"key":"397_CR20","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.amjcard.2005.07.041","volume":"96","author":"JA Beckman","year":"2005","unstructured":"Beckman JA, Preis O, Ridker PM, Gerhard-Herman M. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol. 2005;96:1374\u20138.","journal-title":"Am J Cardiol"},{"key":"397_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7326\/0003-4819-148-2-200801150-00003","volume":"148","author":"H Vidula","year":"2008","unstructured":"Vidula H, Tian L, Liu K, Criqui MH, Ferrucci L, Pearce WH, et al. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med. 2008;148:85\u201393.","journal-title":"Ann Intern Med"},{"key":"397_CR22","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1365-2362.2009.02180.x","volume":"39","author":"J Amighi","year":"2009","unstructured":"Amighi J, Schlager O, Haumer M, Dick P, Mlekusch W, Loewe C, et al. Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease. Eur J Clin Invest. 2009;39:784\u201392.","journal-title":"Eur J Clin Invest"},{"key":"397_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/1538574408316138","volume":"42","author":"AL Hogh","year":"2008","unstructured":"Hogh AL, Joensen J, Lindholt JS, Jacobsen MR, Ostergaard L. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease 95. Vasc Endovascular Surg. 2008;42:341\u20137.","journal-title":"Vasc Endovascular Surg"},{"key":"397_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/eurheartj\/ehm587","volume":"29","author":"G Brevetti","year":"2008","unstructured":"Brevetti G, Schiano V, Laurenzano E, Giugliano G, Petretta M, Scopacasa F, et al. Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. Eur Heart J. 2008;29:224\u201330.","journal-title":"Eur Heart J"},{"key":"397_CR25","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1161\/01.STR.0000190896.67743.b1","volume":"36","author":"JR Davies","year":"2005","unstructured":"Davies JR, Rudd JHF, Fryer TD, Graves MJ, Clark JC, Kirkpatrick PJ, et al. Identification of culprit lesions after transient ischemic attack by combined 18\u00a0F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke. 2005;36:2642\u20137. Lippincott Williams & Wilkins.","journal-title":"Stroke"},{"key":"397_CR26","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.2337\/dc15-0598","volume":"38","author":"ES Siraj","year":"2015","unstructured":"Siraj ES, Rubin DJ, Riddle MC, Miller ME, Hsu F-C, Ismail-Beigi F, et al. Insulin Dose and Cardiovascular Mortality in the ACCORD Trial. Diabetes Care. 2015;38:2000\u20138.","journal-title":"Diabetes Care"},{"key":"397_CR27","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2967\/jnumed.107.050294","volume":"49","author":"JHF Rudd","year":"2008","unstructured":"Rudd JHF, Myers KS, Bansilal S, Machac J, Pinto CA, Tong C, et al. Atherosclerosis inflammation imaging with 18\u00a0F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871\u20138.","journal-title":"J Nucl Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0397-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-016-0397-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0397-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T14:39:43Z","timestamp":1487687983000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0397-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0397-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2016,11,25]]},"article-number":"237"}}